Close Menu

Biolog

The deal covers Biolog's line of cell analysis tools including its Gen III MicroPlate test panel for bacterial species identification.

Researchers from the Greenwood Genetic Center have reported positive results that confirm their earlier findings in an effort to develop a test for autism spectrum disorders using Biolog's phenotype array technology.

The National Institutes of Health has awarded Greenwood Genetic Center $275,000 to support the development of a test for autism spectrum disorders. GGC will use Biolog's Phenotype Microarray platform in the planned two-year study.

NEW YORK (GenomeWeb News) – Biolog today announced new distributors for its products in Europe.

CEO Barry Bochner said that Biolog will use the funds to continue adapting its Phenotype Microarray platform to study Mycobacterium tuberculosis and other fastidious pathogens, expand its Microbial Identification System to cover more fastidious species, and work with researchers at Texas A&M University to study gene function in Mycobacterium.

Appearing in the online editions of Fungal Genetics and Biology and Microbiology, the papers describe the use of Biolog's Phenotype Microarray platform to research secondary pathways in F. graminearum, which is responsible for head blight and crop losses.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.